This cross-sectional study of 47 people found a positive association between systemic Omega-3 Index levels and corneal nerve fiber length, independent of age and diabetes status.
Eye · 4 authors, 2 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This cross-sectional study of 47 people found a positive association between systemic Omega-3 Index levels and corneal nerve fiber length, independent of age and diabetes status.
This prospective, cross-sectional study assessed 47 participants (26 with diabetes, 21 without) with no or mild peripheral neuropathy. It investigated the relationship between systemic omega-3 polyunsaturated fatty acid levels and corneal nerve structure and function. Corneal anatomical parameters were measured with in vivo confocal microscopy, and corneal sensitivity with non-contact esthesiometry. Multiple linear regression, adjusted for age, sex, neuropathy symptom score, diabetes, and dry eye disease, was used. The central result was a positive, independent association between the Omega-3 Index and corneal nerve fiber length (CNFL), with a beta of 0.33 and p-value of 0.02. DHA was also associated with CNFL. No association was found between PUFA levels and corneal sensitivity or immune cell density. A negative correlation between CNFL and cold sensation thresholds was found in diabetes participants only. Limitations include the cross-sectional design, a population with generally low Omega-3 Indices, and the use of a symptom questionnaire for neuropathy classification. The findings suggest a link between systemic omega-3 PUFA levels, particularly DHA, and corneal nerve architecture.